Search

everythinglearnresearchcommunity

for

Search:↓

Calcium pantothenate therapy improved symptoms of discoid lupus erythematosus without side effects.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

No effective treatment exists to stimulate hair growth in atrichia with papular lesions.

Vitamin C derivative may promote hair growth by activating specific genes.

Combining isotretinoin and dapsone effectively treated a challenging scalp condition.

Gabapentin helps with scalp itch, dutasteride works for frontal fibrosing alopecia, and more research is needed for better PCA treatments.

Platelet-rich plasma speeds up burn healing.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Primary cicatricial alopecia is linked to various health issues, indicating broader systemic problems.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Targeting the p300/AR axis may help treat polycystic ovary syndrome.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Standardized PRP therapy can improve treatment for hair loss.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Early recognition and treatment of Peripheral Arterial Disease is crucial to improve survival and health outcomes.

Nonclassic congenital adrenal hyperplasia is a common genetic disorder that can cause a range of symptoms and requires personalized treatment.

Microparticles containing artocarpin extract could effectively treat hair loss and acne with minimal side effects.

Insurance coverage for scalp cooling will make it more accessible to all chemotherapy patients.

The combination of calcipotriol and PRP is the most effective treatment for alopecia areata.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

The ACP's migraine treatment guidelines are flawed and don't prioritize patient safety.

10% carbamide peroxide is safe and effectively reduces mild to moderate acne.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

The U.K. created the CPSA to set safety standards for non-surgical cosmetic treatments and improve patient protection.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

PCA patients have more harmful bacteria and antibiotic resistance, needing specific testing for treatment.